About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Xpatm1Tnka
targeted mutation 1, Kiyoji Tanaka
MGI:2183931
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Xpatm1Tnka/Xpatm1Tnka C3.Cg-Xpatm1Tnka MGI:4361118
hm2
Xpatm1Tnka/Xpatm1Tnka involves: C57BL/6 * CBA MGI:4361117
cx3
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Tnka/Xpatm1Tnka
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:4361119
cx4
Hrhr/Hrhr
Msh2tm1Htr/Msh2tm1Htr
Xpatm1Tnka/Xpatm1Tnka
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:4429631
cx5
Hrhr/Hrhr
Xpatm1Tnka/Xpatm1Tnka
involves: C57BL/6 * CBA MGI:4429632
cx6
Xpatm1Tnka/Xpatm1Tnka
Tg(KRT14-Kitl)1Takk/?
involves: C57BL/6 * CBA * SJL MGI:4361120


Genotype
MGI:4361118
hm1
Allelic
Composition
Xpatm1Tnka/Xpatm1Tnka
Genetic
Background
C3.Cg-Xpatm1Tnka
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Xpatm1Tnka mutation (0 available); any Xpa mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• significantly increased incidence of spontaneous tumors
• aflatoxin B1 induces 2-6 fold higher numbers of hepatocellular adenomas

liver/biliary system
• significantly increased incidence of spontaneous tumors
• aflatoxin B1 induces 2-6 fold higher numbers of hepatocellular adenomas




Genotype
MGI:4361117
hm2
Allelic
Composition
Xpatm1Tnka/Xpatm1Tnka
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Xpatm1Tnka mutation (0 available); any Xpa mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• treatment with benzo(a)pyrene by intratracheal instillation leads to lung adenomas in 71% of homozygotes compared to 35% of controls
• in 10% of mice after treatment with benzo(a)pyrene by intratracheal instillation

growth/size/body
• the weight of males up to 2 years of age is reduced relative to that of controls

cellular
• fibroblasts from newborn mice are highly sensitive to UV radiation (J:28709)
• higher inflammatory edema after UV-B exposure (J:28709)
• skin ulcers form within 1-2 weeks of exposure (J:28709)
• mice develop stronger and longer lasting ear swelling/inflammatory edema after ultraviolet B (UV-B) and topical psoralen plus ultraviolet A (PUVA) radiation indicating increased susceptibility to UV-B and PUVA radiation (J:35054)
• abdominal skin shows intracellular edema and necrosis in the epidermis and subepidermal bullae at 24 hours after UV-B irradiation and mice show marked inflammatory infiltrates of lymphocytes, pronounced edema, vasodilation, and extravasation of erythrocytes in the dermis (J:35054)
• mice develop enhanced sunburn cell formation after UV-B irradiation (J:35054)
• defect in nucleotide excision repair
• failure to remove thymine dimers

neoplasm
• spontaneous tumors begin to appear at around 12 months
• spontaneous tumors are very abundant at 24 months
• in all mice by 34 weeks after UV-B exposure
• treatment with benzo(a)pyrene by intratracheal instillation leads to lung adenomas in 71% of homozygotes compared to 35% of controls
• in 10% of mice after treatment with benzo(a)pyrene by intratracheal instillation
• as a result of exposure to 9,10-dimethyl-1,2benz(a)anthracene (DMBA)
• increased sensitivity to the tumor forming effects of 9,10-dimethyl-1,2benz(a)anthracene (DMBA)

immune system
• UV-B-induced local immunosuppression and UV-B-induced systemic immunosuppression are enhanced when mice are sensitized with DNFB after UV-B irradiation
• however, mice develop contact sensitivity to DNFB similarly to controls
• daily UV-B exposure for 3 or 5 days results in a significantly reduced cell count
• slower recovery
• daily UV-B exposure for 3 or 5 days results in a significantly reduced cell count
• cell activity reduced to significantly below non irradiated levels by 1 day after exposure
• slower recovery
• reduced activity persists at least 5 days
• full recovery of activity by day 10
• mice show a greater loss of and morphologic damage of ADPase (+) Langerhans cells after UV-B irradiation
• recovery of Langerhans cells after UV-B irradiation is slower than for controls

reproductive system
• some degeneration seen at 6 months
• by 12 months half of tubules have vacuoles in the spermatogenic epithelium
• relative testis weight drops progressively over time
• down to 1/3 the weight of testes from control mice at 2 years
• in all seminiferous tubules by 24 months
• lack spermatozoa at 24 months
• males remain fertile until about 30 weeks

homeostasis/metabolism
• defect in nucleotide excision repair
• failure to remove thymine dimers
• PGD2, PGE2 and PGF2alpha levels increase significantly after UV-B irradiation
• increased sensitivity to the tumor forming effects of 9,10-dimethyl-1,2benz(a)anthracene (DMBA)

hematopoietic system
• daily UV-B exposure for 3 or 5 days results in a significantly reduced cell count
• slower recovery
• daily UV-B exposure for 3 or 5 days results in a significantly reduced cell count
• cell activity reduced to significantly below non irradiated levels by 1 day after exposure
• slower recovery
• reduced activity persists at least 5 days
• full recovery of activity by day 10

endocrine/exocrine glands
• some degeneration seen at 6 months
• by 12 months half of tubules have vacuoles in the spermatogenic epithelium
• relative testis weight drops progressively over time
• down to 1/3 the weight of testes from control mice at 2 years

integument
• in all mice by 34 weeks after UV-B exposure

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
xeroderma pigmentosum group A DOID:0110843 OMIM:278700
J:35054




Genotype
MGI:4361119
cx3
Allelic
Composition
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Tnka/Xpatm1Tnka
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc6tm1Gvh mutation (1 available); any Ercc6 mutation (78 available)
Xpatm1Tnka mutation (0 available); any Xpa mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die around 21 days of age

growth/size/body
• low body weight and size develop after birth
• 40% weight reduction at 2 weeks of age

behavior/neurological
• clasp hind limbs when suspended by the tail
• starting around 1 week of age
• clearly evident at 2 weeks of age
• sit with hind limbs spread for balance
• fall down often
• walk with a wide gait
• "waltzing" locomotion

nervous system
• fewer proliferating external granular cells at 8 days
• significantly increased number of apoptotic cells
• impaired foliation and sulcus formation
• 20% brain weight reduction at 2 weeks of age
• dendritic trees are reduced in length
• becomes strikingly small
• normal at birth

cellular
• fewer proliferating external granular cells at 8 days
• significantly increased number of apoptotic cells




Genotype
MGI:4429631
cx4
Allelic
Composition
Hrhr/Hrhr
Msh2tm1Htr/Msh2tm1Htr
Xpatm1Tnka/Xpatm1Tnka
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrhr mutation (18 available); any Hr mutation (87 available)
Msh2tm1Htr mutation (1 available); any Msh2 mutation (95 available)
Xpatm1Tnka mutation (0 available); any Xpa mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 32% of mice die 15 weeks after UVB-irradiation compared with 3% of similarly treated Xpatm1Tnka homozygotes
• 18% of mice die of lymphomas by 20 weeks of age

neoplasm
• in 81% of mice by 52 weeks
• 9% of spontaneous skin tumors are papillomas
• 91% of skin tumors are squamous cell carcinomas
• all skin tumors in UVB-treated mice are diagnosed as squamous cell carcinomas
• 18% of mice die of lymphomas by 20 weeks of age
• UVB-treated mice develop skin tumors a week earlier than similarly treated Xpatm1Tnka homozygotes
• all UVB-treated mice develop skin tumors, all of which are squamous cell carcinomas, at 10 weeks compared with 20 weeks for similarly treated Xpatm1Tnka homozygotes

integument
• in 81% of mice by 52 weeks
• 9% of spontaneous skin tumors are papillomas
• 91% of skin tumors are squamous cell carcinomas
• all skin tumors in UVB-treated mice are diagnosed as squamous cell carcinomas

homeostasis/metabolism
• 32% of mice die 15 weeks after UVB-irradiation compared with 3% of similarly treated Xpatm1Tnka homozygotes




Genotype
MGI:4429632
cx5
Allelic
Composition
Hrhr/Hrhr
Xpatm1Tnka/Xpatm1Tnka
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrhr mutation (18 available); any Hr mutation (87 available)
Xpatm1Tnka mutation (0 available); any Xpa mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• after 20 weeks, 100% of UVB-irradiated mice develop skin tumors

integument
• after 20 weeks, 100% of UVB-irradiated mice develop skin tumors




Genotype
MGI:4361120
cx6
Allelic
Composition
Xpatm1Tnka/Xpatm1Tnka
Tg(KRT14-Kitl)1Takk/?
Genetic
Background
involves: C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(KRT14-Kitl)1Takk mutation (1 available)
Xpatm1Tnka mutation (0 available); any Xpa mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
pigmentation

neoplasm
• mice irradiated with UV-B 3X/week for 10 weeks, total dose 150J/cm2
• unevenly pigmented macules appear on re-epithelialized skin at 4 months after UV-B exposure
• lentigo maligna melanomas eventually become elevated tumors
• black nodular melanomas in some mice by 6 months after exposure
• at 53 weeks, 8 of 61 mice with nodular melanomas and 12 of 61 mice show lintigo maligna melanoma
• one type of tumor or the other, never both
• melanoma cells invade the dermis
• both types of melanomas become metastatic

integument
• mice irradiated with UV-B 3X/week for 10 weeks, total dose 150J/cm2
• unevenly pigmented macules appear on re-epithelialized skin at 4 months after UV-B exposure
• lentigo maligna melanomas eventually become elevated tumors
• black nodular melanomas in some mice by 6 months after exposure
• at 53 weeks, 8 of 61 mice with nodular melanomas and 12 of 61 mice show lintigo maligna melanoma
• one type of tumor or the other, never both

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
skin melanoma DOID:8923 OMIM:608035
OMIM:612263
J:100608





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory